TELES AG INFORMATIONSTECHNOLOGIEN Half-yearly Financial Statements 2022 of the TELES Group
(IFRS, unaudited)
Key figures from January 1, 2022 to June 30, 2022
- Sales HY-2022 of EUR 39.5 million (previous year: EUR 1.224 thousand)
- Gross profit HY-2022 of EUR 2.7 million (previous year: EUR 911 thousand)
- EBITDA HY-2022 of EUR 244 thousand (previous year: EUR -10 thousand)
- Operating cash flow HY-2022 of EUR 741 thousand (previous year EUR -10 thou- sand)
Overview of the corporate key figures of TELES Group for the first six months of 2022 (in accordance with IFRS, unaudited)
TELES Group | 01.01.2021 - | 01.01.2022 - | Change |
in thousand Euro | 30.06.2021 | 30.06.2022 | |
Sales revenues | 1,224 | 39,486 | > +500% |
Cost of materials | 313 | 36,744 | > +500% |
Personnel expenses | 746 | 1,651 | 121% |
Gross profit | 209 | 916 | 339% |
Operating result/EBIT | -99 | 47 | 147% |
EBITDA | -10 | 244 | > +500% |
Group result | -112 | -234 | -109% |
© TELES Aktiengesellschaft | ||
Page 1 of 9 | ||
August 2022 | ||
Interim Management Report
With the Pharma expansion field, TELES opened a new segment at the end of 2021, in which, as in telecommunications software, the management of enormous amounts of data and the digitization of business processes lead to growth spurts.
The earnings situation of the TELES Group improved significantly in the first half of 2022 compared to the same period of the previous year. The reason for this is the inclusion of EURO RX Arzneimittel GmbH in the consolidated financial statements since January 2022. The TELES Group achieved sales revenues of EUR 39.5 million (previous year: EUR 1,224 thousand). The gross profit increased accordingly to EUR 2.7 million (previous year: EUR 911 thousand).
Personnel expenses increased by 121% to EUR 1,651 thousand (previous year: EUR 746
thousand). Depreciation amounted to EUR 197 thousand (prior year: EUR 89 thou-
sand). Other operating income was EUR 69 thousand (previous year: EUR 34 thousand).
With the increase in other operating expenses of EUR 916 thousand (previous year: 209
thousand), the EBITDA was EUR 244 thousand (previous year: -10 thousand) and the
consolidated result at EUR -234 thousand (previous year: EUR -112 thousand).
The balance sheet total of TELES increased by EUR 10.3 million compared to the previous year. This is due to the increase in current assets by EUR 10.0 million.
In the cash flow statement, the operating cash flow is EUR 741 thousand (previous year: EUR -70 thousand). The investment activity of EUR 721 thousand is primarily characterized by investments in fixed assets for EURO RX Arzneimittel GmbH. As of June 30, 2021, the financial resources were EUR 1.3 million (previous year; EUR 644 thousand).
© TELES Aktiengesellschaft | ||
Page 2 of 9 | ||
August 2022 | ||
Risk Report
In the management report for the past 2021 fiscal year, all relevant risks known to us were listed conscientiously. Nothing to add now. We ensure the company's liquidity through very conscientious planning. We continue to monitor incoming payments very closely and thus counteract payment defaults on the part of customers. Whether the sales and earnings targets will be achieved depends - apart from internal company factors - to a significant extent on economic, political and industry-specific developments − particularly in our core market of Europe.
Forecast
For the current fiscal year, we expect sales of EUR 60 to 70 million and a positive result (EBIT) of EUR 300 to 500 thousand for the TELES Group.
TELES AG Informationstechnologien
Oliver Olbrich
Chief Executive Officer
August 2022
© TELES Aktiengesellschaft | ||
Page 3 of 9 | ||
August 2022 | ||
Interim Financial Statements
Consolidated Balance Sheet (IFRS, unaudited)
in thousand Euro | 31.12.2021 | 30.06.2022 | ||
Assets | ||||
A. | Fixed assets | |||
I. | Intangible assets | 0 | 32 | |
II. | Tangible assets | 250 | 1,829 | |
III. | Financial assets | 1,894 | 582 | |
Total fixed assets | 2,144 | 2,443 | ||
B. | Current assets | |||
I. | Stocks | 5 | 4,068 | |
II. | Trade receivables and other receivables | 351 | 4,440 | |
III. | Other assets | 95 | 1,031 | |
IV. Cheque, Cash at bank and in hand | 391 | 1,283 | ||
Total current assets | 842 | 10,822 | ||
Prepayments and accrued income | 48 | 73 | ||
Total assets | 3,034 | 13,337 | ||
© TELES Aktiengesellschaft | ||
Page 4 of 9 | ||
August 2022 | ||
in thousand Euro | 31.12.2021 | 30.06.2022 | |
Equity and liabilities | |||
A. | Equity | ||
I. | Ordinary shares | 6,233 | 6,233 |
II. | Capital reserve | 242 | 242 |
III. | Revenue reserves | ||
Loss carried forward | -4,906 | -4,906 | |
Profit or loss for the period | 0 | -235 | |
Total equity | 1,569 | 1,334 | |
B. | Minority interest | 0 | 365 |
C. | Provisions | ||
I. | Tax provisions | 625 | 1,006 |
II. | Other provisions | 156 | 348 |
Total provisions | 780 | 1,354 | |
D. | Creditors | ||
I. | Financial liabilities | 0 | 7,799 |
II. | Payment received on account | 58 | 25 |
III. | Trade creditors | 210 | 1,197 |
IV. | Other creditors | 288 | 1,046 |
Total creditors | 556 | 10,067 | |
E. | Deferred income | 129 | 213 |
F. | Deferred taxes | 0 | 4 |
Total equity and liabilities | 3,034 | 13,337 | |
© TELES Aktiengesellschaft | ||
Page 5 of 9 | ||
August 2022 | ||
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
TELES AG Informationstechnologien published this content on 01 August 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 01 August 2022 15:04:05 UTC.
